The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2

Sexually Transmitted Infections

Volumn 87, Issue 4, 2011, Pages 301-305

  De Bruyn, Guy ^a   Shiboski, Stephen ^b   Van Der Straten, Ariane ^c,d   Blanchard, Kelly ^e   Chipato, Tsungai ^f   Ramjee, Gita ^g   Montgomery, Elizabeth ^d   Padian, Nancy ^c,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RTI INTERNATIONAL   (United States)

^e IBIS REPRODUCTIVE HEALTH   (United States)

^f UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^g SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LUBRICATING AGENT; VIRUS ANTIBODY;

ADULT; ARTICLE; CONDOM; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOASSAY; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SINGLE BLIND PROCEDURE; SOUTH AFRICA; UTERINE CERVIX CAP; ZIMBABWE;

ADOLESCENT; ADULT; CONDOMS; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; LIPIDS; LUBRICANTS; MIDDLE AGED; SEXUAL PARTNERS; SOUTH AFRICA; YOUNG ADULT; ZIMBABWE;

EID: 79956281655     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.047142     Document Type: Article

References (19)

1. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83.
2. Brown JM, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. Aids 2007;21:1515-23. (Pubitemid 47075471)
3. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003;187:1513-21. (Pubitemid 36578957)
4. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52. (Pubitemid 34043015)
5. Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: a key role in HIV incidence. Aids. 2009;23:1595-8.
6. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009;169:1233-40.
7. Chohan VH, Baeten J, Benki S, et al. A prospective study of risk factors for herpes simplex virus Type 2 acquisition among high-risk HIV-1 seronegative Kenyan women. Sex Transm Infect 2009;85:489.
8. Tobian AA, Charvat B, Ssempijja V, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis 2009;199:945-9.
9. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-6. (Pubitemid 32578207)
10. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007;370:2127-37. (Pubitemid 350296304)
11. Maguire RA, Bergman N, Phillips DM. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm Dis 2001;28:259-65. (Pubitemid 32402143)
12. Mesquita PM, Wilson SS, Manlow P, et al. Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model. J Virol 2008;82:6576-84. (Pubitemid 351875134)
13. Tuyama AC, Cheshenko N, Carlucci MJ, et al. ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J Infect Dis 2006;194:795-803. (Pubitemid 44344127)
14. Rosenthal KS, Killius J, Hodnichak CM, et al. Mild acidic pH inhibition of the major pathway of herpes simplex virus entry into HEp-2 cells. J Gen Virol 1989;70:857-67. (Pubitemid 19099635)
15. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007;370:251-61. (Pubitemid 47069513)
16. Hogrefe W, Su X, Song J, et al. Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol 2002;40:3635-40.
17. van der Straten A, Shiboski S, Montgomery ET, et al. Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr 2009;50:419-26.
18. Rupp R, Rosenthal SL, Stanberry LR. VivaGel (SPL7013 Gel): a candidate dendrimere microbicide for the prevention of HIV and HSV infection. Int J Nanomedicine 2007;2:561-6.
19. Karim QA, Karim SS, Frohlich JA, et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science 2010;329:1168-74.